Investor Relations
The investor pages that follow are your resource for financial information about Alexion Pharmaceuticals, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Please click here to view our SEC filings
Transfer Agent and Registrar
Continental
Stock Transfer & Trust Company
17 Battery Place
New York, New York
10004
Note: Alexion Pharmaceuticals, Inc. provides this data for informational and research purposes only. The data is not intended for trading purposes. Neither Alexion nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Recent Releases
Jun 19, 2009
Alexion Extends Its Commitment to a Green Footprint Through Its Ambitious New Solar Energy System
Jun 10, 2009
Alexion's Soliris(R) Receives 2009 Prix Galien France for Most Innovative Drug for Rare Disease
Events
Jun 17, 2009
Jefferies 3rd Annual Healthcare Conference
Jun 10, 2009
8th Annual Needham Life Sciences Conference
